Joint evaluation of serum C-Reactive Protein levels and polygenic risk scores as risk factors for schizophrenia

Vishwajit L. Nimgaonkar, Faith Dickerson, Jennie G. Pouget, Kodavali Chowdari, Colm O'Dushlaine, Joel Wood, Lambertus Klei, Bernie Devlin, Robert H Yolken

Research output: Contribution to journalArticle

Abstract

Several studies have indicated infectious and immune-related abnormalities in schizophrenia (Scz), including elevated serum C-reactive protein (CRP) - a well-known proxy for infections/immune abnormalities. A portion of the genetic risk for Scz can be estimated using the polygenic risk score (PGRS). It is not known whether there is an interaction in the risks traceable to CRP and PGRS. Patients with Scz and individuals without psychosis were evaluated systematically using DSM IV criteria (N=794, N=446, respectively). To estimate risk for Scz attributable to CRP and PGRS, serum from these participants was assayed for CRP levels using enzyme linked immunosorbent assays. PGRS was estimated from common DNA polymorphisms associated with Scz from genome wide association studies. CRP level and PGRS were not significantly correlated. Using a generalized linear logistic model, case/control status was evaluated in relation to the following predictors: CRP, PGRS, and demographic variables. CRP and PGRS were individually associated with case status; CRP: odds ratio (OR) 1.27, 95% confidence intervals (95% CI) 1.12, 1.43; p = 0.0001; PGRS: OR 1.66, 95% CI 1.47, 1.89; p = 1.28 ×1015. There were no significant interactions between PGRS and CRP for predicting Scz versus control status.

Original languageEnglish (US)
Pages (from-to)148-153
Number of pages6
JournalPsychiatry Research
Volume261
DOIs
Publication statusPublished - Mar 1 2018

    Fingerprint

Keywords

  • C Reactive Protein
  • Genetic association
  • Polygenic risk score
  • Schizophrenia
  • SNP

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this